Wednesday, 28 February, 2024

04 Apr 2012 | Press Release

news > News and Events > Page 1

Straumann shareholders approve all proposals of the Board of Directors at AGM

Company Reporting and Announcements

At Straumann's Annual General Meeting (AGM) today in Basel, the shareholders approved all the proposals put forward by the Board of Directors. 491 shareholders attended the meeting and a total of 10,166,573 voting shares were represented, corresponding to 65% of the overall share capital.


Annual Report and Compensation Report approved
The shareholders approved the 2011 Annual Report, the 2011 Financial Statements and the discharge of the Board of Directors for their activities in 2011. In an advisory vote, they also consented to the 2011 Compensation Report, which includes a new remuneration model.

PricewaterhouseCoopers of Basel was reappointed as Statutory Auditors and Group Auditors for a further term of one year.

Board of Directors confirmed
All the Directors of the Straumann Board - Gilbert Achermann (Chairman), Dr Sebastian Burckhardt, Dominik Ellenrieder, Roland Hess, Ulrich Looser, Dr Beat Luthi, Stefan Meister and Dr h.c. Thomas Straumann (Vice Chairman) - were re-elected for a further one-year term of office.

Stable dividend
The meeting approved the appropriation of the available earnings. CHF 34 million were allocated to the 2011 dividend, corresponding to CHF 2.20 per share. The shareholders also approved the use of CHF 24 million to pay CHF 1.55 of the total dividend per share out of 'reserves for capital contributions'. Thus, Straumann is maintaining the same payout as in previous years, resulting in a dividend yield of 2.4%. The payout of CHF 3.75 per share will be made as of 13 April 2012.

2013 AGM
The next ordinary general meeting of Straumann's shareholders will be convened on 5 April 2013 at the Basel Congress Center.

About Straumann
Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 2450 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.

Related Contacts

Abstracts

Clinical

Techniques

Staying Safe

Stream the latest dental videos...
VITA ENAMIC Reworking Tutorial

Sponsored Links...

Upcoming Events...

Feb 29 2024
Mar 06 2024
Mar 09 2024
Mar 12 2024
Mar 13 2024
Mar 13 2024
Mar 14 2024

Expodental 2024

Madrid, SPAIN

Mar 15 2024
Mar 16 2024
Mar 21 2024

ADX24 Sydney

Sydney, AUSTRALIA

Mar 22 2024
Apr 05 2024
Apr 12 2024
Apr 16 2024

Dentists Behaving 'Very' Badly

Brisbane, AUSTRALIA

Apr 19 2024
Apr 19 2024

IDEM Singapore 2024

Singapore, SINGAPORE

Apr 23 2024
Apr 24 2024
May 01 2024
May 02 2024
May 09 2024
May 11 2024
May 14 2024
May 22 2024
May 24 2024
May 29 2024
May 30 2024
May 31 2024

Scottish Dental Show 2024

Glasgow, UNITED KINGDOM

May 31 2024

Famdent Show Mumbai 2024

Mumbai, INDIA

Jun 01 2024
Jun 06 2024
Jun 09 2024
Jun 11 2024
Jun 22 2024
Jul 16 2024
Jul 25 2024
Aug 23 2024
Aug 29 2024

Practical Endodontics Workshop

Sydney, AUSTRALIA

Sep 07 2024
Sep 14 2024
Sep 26 2024
Oct 03 2024
Oct 10 2024
Oct 17 2024

ADOHTA 2024 National Congress

Sydney, AUSTRALIA

Oct 24 2024
Nov 13 2024
Nov 29 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025